Ooma, Inc. (NYSE: OOMA), a smart communications platform for businesses and consumers, today announced the following conference participation:
What: 25th Annual Needham Growth Conference, presentation and investor meetings
When: Presentation (fireside chat) 3:45 p.m. until 4:25 p.m. Eastern time on January 11, 2023, with meetings throughout the day
Who: Ooma CEO Eric Stang and Ooma CFO Shig Hamamatsu
Where: Lotte New York Palace hotel, New York, New York
Interested parties should contact their Needham & Company sales representative for further details and meeting opportunities.
About Ooma, Inc.
Ooma (NYSE: OOMA) creates powerful connected experiences for businesses and consumers, delivered from its smart cloud-based SaaS platform. For businesses of all sizes, Ooma provides advanced voice and collaboration features including messaging, intelligent virtual attendants and videoconferencing to help them run more efficiently. For consumers, Ooma's residential phone service provides PureVoice HD voice quality, advanced functionality and integration with mobile devices. Learn more at www.ooma.com or www.ooma.ca in Canada.
Nextracker , a global provider of intelligent solar tracker and software solutions, today announced the availability of its flagship NX Horizontm solar tracker system with up to 35% lower carbon footprint. Marking a significant milestone for solar...
Rasa, a leader in generative conversational AI, proudly announces its recognition as a Representative Vendor in the Gartner® Market Guide for Conversational AI Solutions. Rasa believes this acknowledgment highlights its pivotal role in the future of...
Amazon today announced a new grocery delivery subscription benefit now available to Prime members and customers using EBT in more than 3,500 cities and towns across the U.S. At $9.99 per month for Prime members, this subscription offers unlimited...
Nuclear SMRs (small modular reactors) aim to take advantage of assembly line production to reduce cost and construction time compared to the large reactors that form the bulk of today's nuclear fleet. Their smaller size and frequent use of advanced...
BeiGene, Ltd. , a global oncology company, today announced that the European Commission (EC) has approved tislelizumab as a treatment for non-small cell lung cancer (NSCLC) across three indications, including first- and second-line use....